Affordable Access

[Chronic hepatitis delta--the course and approaches to therapy].

Authors
Type
Published Article
Journal
Klinicheskaia meditsina
Publication Date
Volume
69
Issue
3
Pages
85–88
Identifiers
PMID: 2067348
Source
Medline
License
Unknown

Abstract

Variants of chronic hepatitis delta (CHD) course were studied in 94 patients. Slow progress (for decades) occurred most frequently, while rapid progress to hepatic cirrhosis (for 1-2 years) or benign course presenting as greater than 3-year remission were rare findings. In addition to routine therapeutic modalities, except corticosteroids, 43 CHD patients received recombinant alpha 2-interferon (reaferon). Follow-up results evaluated separately for hepatic cirrhosis and free of it CHD patients support clinical promise of Soviet recombinant alpha 2-interferon against CHD.

Statistics

Seen <100 times